SC
AEON.WS

Sculptor Capital’s AEON Biopharma Inc AEON.WS Stock Holding History

Sculptor Capital’s Portfolio AEON.WS Stock Details AEON.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-50,040
Closed -$76.3K – 388
2024
Q1 		$76.3K Hold
50,040
– – ﹤0.01% 236
2023
Q4 		$4.37K Hold
50,040
– – ﹤0.01% 343
2023
Q3 		$8K Sell
50,040
-13,226
-21% -$1.88K ﹤0.01% 366
2023
Q2 		$5.38K Sell
63,266
-2,400
-4% -$180 ﹤0.01% 412
2023
Q1 		$4.3K Hold
65,666
– – ﹤0.01% 510
2022
Q4 		$2.46K Sell
65,666
-1,000
-2% -$40 ﹤0.01% 764
2022
Q3 		$5K Hold
66,666
– – ﹤0.01% 1031
2022
Q2 		$11K Hold
66,666
– – ﹤0.01% 1089
2022
Q1 		$21K Buy
66,666
+16,666
+33% +$6.88K ﹤0.01% 1167
2021
Q4 		$26K Hold
50,000
– – ﹤0.01% 1107
2021
Q3 		$29K Hold
50,000
– – ﹤0.01% 939
2021
Q2 		$51K Buy
+50,000
New +$38K ﹤0.01% 901

Sculptor Capital's AEON.WS Position: Q2 2024 in Review

Sculptor Capital sold out of AEON Biopharma Inc (AEON.WS) in Q2 2024, closing a stake of 50,040 shares — an estimated $76.3K sold.

Sculptor Capital first reported a position in AEON.WS in Q2 2021 and held it in 12 quarters. The position peaked at $76.3K in Q1 2024. 0 funds tracked by Wall St. Rank hold AEON.WS as of Q2 2024.

  • Sculptor Capital reported no remaining AEON Biopharma Inc position as of Q2 2024 after selling out during the quarter.
  • Sculptor Capital sold 50,040 AEON Biopharma Inc shares in Q2 2024, an estimated $76.3K.
  • Sculptor Capital first reported a position in AEON Biopharma Inc in Q2 2021 and held it in 12 quarters.
  • Sculptor Capital's AEON Biopharma Inc position peaked at $76.3K in Q1 2024.
  • 0 funds tracked by Wall St. Rank held AEON Biopharma Inc as of Q2 2024.

Based on Sculptor Capital's 13F filing for Q2 2024, filed 14 Aug 2024.